Maynard Um
-
-
-
-
-
-
-
Crinetics (CRNX) PT Lowered to $84 at Oppenheimer
-
-
-
-
-
-
-
Crinetics Pharmaceuticals (CRNX) Tops Q4 EPS by 5c
-
-
-
-
-
-
-
Baird on Crinetics (CRNX): 'Palsonify off to a great start, expect upwards revision to estimates'
-
-
-
-
-
-
-
Crinetics (CRNX) PT Raised to $87 at Oppenheimer
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX)
-
-
-
-
-
-
-
Crinetics (CRNX) PT Lowered to $86 at Citizens JMP
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Crinetics (CRNX)
-
406,388 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

